Cannabis Europa 2025: Inside the Summit Shaping Europe's Green Future
As reform ripples across Europe, Cannabis Europa returns to London on June 24–25, assembling the continent’s most powerful minds in policy, science, and business. Held at the iconic Barbican Centre, the 2025 edition arrives at a critical juncture: Germany is advancing federal legalization, Switzerland is piloting regulated distribution models, and markets like the UK and Czech Republic are rethinking outdated frameworks.
Presented by Prohibition Partners—the global intelligence agency known for mapping the future of plant-based industries—Cannabis Europa is more than a conference. It’s where Europe’s next era is being designed in real time. The two-day summit promises rigorous discussion around regulatory harmonization, medical standards, and the increasing demand for data-driven solutions. With a growing emphasis on ESG, sustainability, and pharmaceutical consistency, the event aims to chart a responsible, scalable path for long-term industry success.
This year’s programming is set to spotlight leading voices in European governance and science, including Ludovic Mendes of the French National Assembly; Dr. Sarah Wollaston, former UK MP and physician; and esteemed researchers like Prof. Sir Robin Murray and Dr. Marta Di Forti of King’s College London. Alongside them, investors, operators, and strategists will unpack key topics such as building patient trust, navigating international trade, and aligning business models with evolving health systems.
The conference also features a curated expo with over 40 global companies showcasing innovations in biotech, supply chain logistics, and pharmaceutical-grade wellness. But what truly sets Cannabis Europa apart is its unapologetic focus on clinical rigor, regional nuance, and patient-first practices.
At the forefront of this movement is PHCANN International, this year’s headlining sponsor and one of Europe’s most dynamic forces in medical-grade cultivation and distribution. Recently featured in Honeysuckle Magazine’s Mary Jane Berlin edition, PHCANN’s presence underscores a shift in the industry: from hype to high standards. CEO Sasho Stefanoski, who previously led national healthcare systems, will bring a unique perspective to the stage, exploring how public health experience can shape better access, compliance, and scalability across emerging markets. From their state-of-the-art EU-GMP facility in Macedonia to supply lines in Germany, Poland, and Australia, PHCANN’s story reflects the very future Cannabis Europa seeks to build.
As conversations unfold inside the Barbican’s halls, one thing is clear: Europe’s time is now. For anyone serious about the future of global plant-based wellness, Cannabis Europa 2025 is where strategy meets substance—and where tomorrow’s blueprint is being drawn.
For tickets visit here for ticket link.
